Ashley Lawrenson/LinkedIn
Nov 14, 2025, 10:11
Ashley Lawrenson on Her Coagulation Journey Using Automation With the HemoCell and HemoHub
Ashley Lawrenson, Coagulation Section Lead at Liverpool University Hospitals NHS Foundation Trust, shared on LinkedIn:
”Sometimes, you have to step outside your comfort zone and say yes to opportunities…
A huge thank you to Werfen for inviting me to share Liverpool Clinical Laboratories (LCL) Coagulation journey using automation with the HemoCell and HemoHub.
It was a great opportunity to reflect on how these advancements have transformed our department and ultimately improved outcomes for our patients.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial